BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
BEGIN:VEVENT
UID:a3c4d118f37e123f45a19949daa7bde1
DTSTAMP:20260422T111228Z
DTSTART:20260304T160000
DTEND:20260304T173000
SUMMARY:Learning agenda on hepatitis B birth dose vaccine delivery in Africa: Insights and recommendations
DESCRIPTION:Learning agenda on hepatitis B birth dose vaccine delivery in Africa \nInsights and recommendations to improve timely administration\nWednesday 4 March at 16:00–17:30 EAT | 14:00–15:30 CET | 8:00–9:30 EST\nChronic hepatitis B affects 254 million people globally, with the highest burden in low‑ and middle‑income countries, especially in the WHO African Region. While WHO recommends giving the hepatitis B birth‑dose vaccine within 24 hours to prevent vertical transmission, many countries struggle to achieve timely coverage, particularly where a large share of births occur at home. \nIn 2025, Gavi partnered with Unitaid and PATH to launch the Hepatitis B Birth Dose Learning Agenda. In this webinar, we will share insights from a mixed‑methods assessment in Ethiopia, The Gambia, Nigeria, and Uganda to evaluate the feasibility, acceptability, cost, and impact of strategies to improve timely birth‑dose vaccination for infants born in both facility and community settings. \nPlease join us to explore key findings from this work and hear insights from a diverse panel of country experts committed to eliminating vertical transmission of preventable diseases. Participants will have an opportunity to ask questions during the live Q&A.\nPlease register in advance: https://tinyurl.com/hepb-bd
X-ALT-DESC;FMTTYPE=text/html:\n\n\n\n\n\n\n\n\nLearning agenda on hepatitis B birth dose vaccine delivery in Africa
Insights and recommendations to improve timely administration
Wednesday 4 March at 16:00–17:30 EAT | 14:00–15:30 CET | 8:00–9:30 EST
Chronic hepatitis B affects 254 million people globally, with the highest burden in low‑ and middle‑income countries, especially in the WHO African Region. While WHO recommends giving the hepatitis B birth‑dose vaccine within 24 hours to prevent vertical transmission, many countries struggle to achieve timely coverage, particularly where a large share of births occur at home.
In 2025, Gavi partnered with Unitaid and PATH to launch the Hepatitis B Birth Dose Learning Agenda. In this webinar, we will share insights from a mixed‑methods assessment in Ethiopia, The Gambia, Nigeria, and Uganda to evaluate the feasibility, acceptability, cost, and impact of strategies to improve timely birth‑dose vaccination for infants born in both facility and community settings.
Please join us to explore key findings from this work and hear insights from a diverse panel of country experts committed to eliminating vertical transmission of preventable diseases. Participants will have an opportunity to ask questions during the live Q&A.
Please register in advance: https://tinyurl.com/hepb-bd
\n\n\n
LOCATION:
END:VEVENT
END:VCALENDAR